Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Title Fractioned CO2 Laser in the Treatment of Chronic Phase Peyronie's Disease

NCT07177833 is registered in ClinicalTrials.gov with Ottawa Hospital Research Institute as lead sponsor.

NCT NCT07177833
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07177833 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Title Fractioned CO2 Laser in the Treatment of Chronic Phase Peyronie's Disease
Lead sponsor
Ottawa Hospital Research Institute
Phase
Phase 1
Overall status
Recruiting
Start date
October 1, 2025
Completion date
October 1, 2027
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

peyronies disease